Zhifa Wang

11PUBLICATIONS
15CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthEpidemiological modellingHaematologyPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 22, 2025
Daratumumab in Pediatric Chronic Refractory Primary Immune Thrombocytopenia (ITP): Rapid Platelet Recovery, Sustained Response, and Immune Reconstitution Dynamics.

Yu Hu, Hui Chen, Zhifa Wang

|Jul 16, 2025
Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical care.

Jingyao Ma, Chang Cui, Juntao Ouyang

|Jan 05, 2025
Long-term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real-world observational study.

Nan Wang, Zhifa Wang, Jingjing Liu

|Dec 18, 2024
Clinical Use of Eltrombopag and Avatrombopag in Pediatric ITP in China: A Real-World Multicenter Retrospective Cohort Study.

Jingjing Liu, Zhifa Wang, Nan Wang

|Sep 03, 2024
Exploratory study on the individualized application of eltrombopag in paediatric immune thrombocytopenia guided by therapeutic drug monitoring.

Shuyue Dong, Zhifa Wang, Nan Wang

|Jun 04, 2024
The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China.

Yu Hu, Zhifa Wang, Jingyao Ma

Pageof 2

Frequent Collaborators

9 joint publications

Xiaoling Cheng

9 joint publications

Runhui Wu

4 joint publications

Shuyue Dong

3 joint publications

Nan Wang